Aardvark TherapeuticsAARD
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 49 institutions reported holding Aardvark Therapeutics Inc. (AARD) in their 13F filings, up 14 from Q2 2025. 15 opened new positions and 1 sold out. The largest holders were Decheng Capital LLC ($52.1M), Citadel Advisors ($18.1M) and Laurion Capital Management LP ($14.0M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Aardvark Therapeutics Inc.
- CUSIP
- 002942100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 15 | $8.1M |
| Exits | 1 | $10.8M |
All 13F filers, Q2 2025 → Q3 2025: 1,387,739 shares bought and 842,549 shares sold, net +545,190 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 49 holders
| Decheng Capital LLC | 9.08% | No change | 3,917,299 | $52.1M |
| Citadel Advisors | 0.01% | Add +5.9% | 1,359,883 | $18.1M |
| Laurion Capital Management LP | 2.05% | Add +6.1% | 1,049,721 | $14.0M |
| Vanguard Group Inc. | 0.00% | Add +20.6% | 555,721 | $7.4M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | Add +100.0% | 350,000 | $4.7M |
| Millennium Management | 0.00% | New | 319,623 | $4.2M |
| BlackRock, Inc. | 0.00% | Add +50.4% | 309,465 | $4.1M |
| Silverarc Capital Management, LLC | 0.59% | Add +7.0% | 306,912 | $4.1M |
| Schonfeld Strategic Advisors LLC | 0.02% | Reduce -9.1% | 253,752 | $3.4M |
| Geode Capital Management, LLC | 0.00% | Add +41.7% | 194,035 | $2.6M |
| Cresset Asset Management, LLC | 0.01% | New | 141,783 | $1.9M |
| Cantor Fitzgerald, L. P. | 0.03% | Add +26.1% | 96,682 | $1.3M |
| State Street Corp. | 0.00% | Add +149.3% | 93,005 | $1.2M |
| Morgan Stanley | 0.00% | Add +664.1% | 68,462 | $910K |
| Two Sigma Investments, LP | 0.00% | New | 63,569 | $845K |
| Northern Trust Corp. | 0.00% | Add +26.9% | 57,197 | $760K |
| BNP Paribas Financial Markets | 0.00% | Add +59.3% | 56,546 | $751K |
| UBS Group AG | 0.00% | Add +5.4% | 54,728 | $727K |
| Barclays PLC | 0.00% | Reduce -21.0% | 39,926 | $531K |
| Two Sigma Advisers, LP | 0.00% | New | 25,700 | $342K |
| Bank of America Corp. | 0.00% | Add +199.5% | 23,930 | $318K |
| Bridgeway Capital Management, LLC | 0.01% | New | 22,000 | $292K |
| Jane Street Group, LLC | 0.00% | New | 19,447 | $258K |
| Goldman Sachs Group Inc. | 0.00% | Add +1.8% | 18,927 | $252K |
| Bank of New York Mellon Corp | 0.00% | New | 15,523 | $206K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 14,240 | $189K |
| Deutsche Bank AG | 0.00% | No change | 5,725 | $76K |
| Rhumbline Advisers | 0.00% | Add +3.9% | 5,705 | $76K |
| Wells Fargo & Company | 0.00% | Add +20.9% | 3,917 | $52K |
| New York State Common Retirement Fund | 0.00% | Reduce -47.6% | 3,823 | $51K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Reduce -16.4% | 2,585 | $34K |
| JPMorgan Chase & Co. | 0.00% | Reduce -13.5% | 2,316 | $31K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | New | 2,120 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -6.5% | 1,185 | $16K |
| STRS Ohio | 0.00% | No change | 1,100 | $15K |
| Stone House Investment Management, LLC | 0.00% | New | 1,000 | $13K |
| Legal & General Group Plc | 0.00% | No change | 587 | $8K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 578 | $8K |
| Russell Investments Group, Ltd. | 0.00% | New | 469 | $6K |
| FMR LLC | 0.00% | New | 363 | $5K |
| California State Teachers Retirement System | 0.00% | Add +0.3% | 355 | $5K |
| Royal Bank of Canada | 0.00% | Add +13.8% | 305 | $4K |
| Amalgamated Bank | 0.00% | No change | 193 | $3K |
| Sterling Capital Management LLC | 0.00% | Add +142.7% | 182 | $2K |
| Citigroup Inc. | 0.00% | Reduce -91.5% | 167 | $2K |
| PNC Financial Services Group, Inc. | 0.00% | New | 140 | $2K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 60 | $797 |
| Arax Advisory Partners | 0.00% | New | 21 | $280 |
| Cwm, LLC | 0.00% | New | 15 | $0 |
"% of holder's portfolio" is AARD's weight in each manager's 13F, not the share of Aardvark Therapeutics Inc. the manager owns.